More than 36.5 million mental health appointments were delivered in VA settings in a single year, yet only a portion of those service members ever appear in PTSD screening and diagnosis counts, creating a gap worth understanding. PTSD risk, co occurring conditions like hazardous alcohol use, and treatment access all move together but not always in the same direction, from early post deployment screening to telehealth sessions and specialty care timeliness. This post connects the dots across PTSD monitoring and care, with figures that make the real patterns impossible to ignore.
Key Takeaways
- In 2023, the PCL-5 scoring guidance documents reported use of the PCL-5 by clinicians in VA and DoD settings for PTSD symptom monitoring
- In FY 2021, VA reported 1.9 million veterans received at least one PTSD-related clinical contact within mental health specialty care
- In 2023, 48% of military health stakeholders reported using digital/telehealth tools for behavioral health screening and monitoring for PTSD symptoms (survey-based)
- 6.0% of U.S. veterans reported PTSD in 2013, according to the VA’s analysis of the National Health Interview Survey (NHIS)
- 8.5% of OEF/OIF veterans had PTSD (current) in 2010, based on the U.S. Department of Veterans Affairs’ analysis of the National Survey of Veterans
- 20% of U.S. military personnel deployed to Iraq or Afghanistan who sought care at VA mental health clinics screened positive for PTSD in the early post-deployment period (measured using standard screening tools)
- From 2010 to 2019, VA’s PTSD specialty care expansion increased the number of veterans receiving specialty PTSD treatment by 48% (VHA reported growth in specialty clinics)
- In FY 2023, the Veterans Health Administration (VHA) provided 36.5 million mental health appointments across all mental health conditions
- In 2019-2020, 34% of active-duty service members who screened positive for PTSD symptoms reported receiving mental health treatment within the prior 12 months
- In a 2016 study, PTSD is associated with a 1.9x increase in health care utilization (measured as visits) compared with non-PTSD cohorts
- $1.0 billion annual cost attributable to comorbid PTSD and depression in veterans in a 2017 claims analysis
- $19.5 billion total societal cost estimate for PTSD in the U.S. in 2010 (including employment and criminal justice costs)
- In a randomized trial, prolonged exposure therapy achieved a 70% response rate vs 60% for present-centered therapy (2012 study)
- In a randomized trial, cognitive processing therapy yielded a 59% remission rate vs 36% for control at post-treatment (2013)
- A meta-analysis reported that trauma-focused CBT reduced PTSD symptom severity with a standardized mean difference (SMD) of about -1.2 versus controls
About 6% of US veterans had PTSD in 2013, and many treated it with evidence based therapies.
Related reading
01 · Category
Industry Trends11 stats
01
In 2023, the PCL-5 scoring guidance documents reported use of the PCL-5 by clinicians in VA and DoD settings for PTSD symptom monitoring
02
In FY 2021, VA reported 1.9 million veterans received at least one PTSD-related clinical contact within mental health specialty care
03
In 2023, 48% of military health stakeholders reported using digital/telehealth tools for behavioral health screening and monitoring for PTSD symptoms (survey-based)
04
A 2023 report projected the global digital mental health market to reach $4.8 billion by 2026, supporting tools used for PTSD screening and therapy delivery
05
In 2022, the global telemedicine market reached $60.5 billion and is projected to grow, relevant to tele-PTSD care delivery
06
By 2022, the DoD had established over 20 operational resilience/behavioral health programs aimed at reducing PTSD risk through early intervention and monitoring
07
In 2023, approximately 1,500 VA clinicians completed PTSD training via the VA National Center for PTSD (NCCPT) learning materials (training throughput)
08
In 2022, 900+ VA staff completed Prolonged Exposure (PE) training modules and workshops (NCCPT training availability)
09
In 2024, the U.S. Digital Health market forecast anticipates tele-mental health products to exceed $5B by 2027 (investment trend relevant to PTSD)
10
In 2022, 46% of mental health apps in the Apple App Store listed evidence-based therapy approaches (including CBT approaches relevant to PTSD) in an app market analysis
11
In 2023, the DoD’s Military Health System reported that 70% of at-risk personnel received some form of behavioral health screening within required workflows (process metric)
Interpretation
Industry Trends Interpretation
Industry Trends in military PTSD care are clearly shifting toward digital and standardized early monitoring, with 48% of stakeholders using digital or telehealth tools for screening and monitoring in 2023 and DoD reporting that 70% of at-risk personnel received behavioral health screening within required workflows in 2023.
02 · Category
Epidemiology8 stats
01
6.0% of U.S. veterans reported PTSD in 2013, according to the VA’s analysis of the National Health Interview Survey (NHIS)
02
8.5% of OEF/OIF veterans had PTSD (current) in 2010, based on the U.S. Department of Veterans Affairs’ analysis of the National Survey of Veterans
03
20% of U.S. military personnel deployed to Iraq or Afghanistan who sought care at VA mental health clinics screened positive for PTSD in the early post-deployment period (measured using standard screening tools)
04
10% of National Guard members returning from deployment screened positive for PTSD in a 2012 study (using the PTSD Checklist)
05
23% of active-duty service members reported clinically significant PTSD symptoms at baseline in a 2019 cohort study of post-deployment behavioral health
06
18% of veterans with histories of combat exposure had PTSD symptoms in a 2018 meta-analysis of prevalence across studies (pooled prevalence for PTSD symptoms)
07
14% of U.S. service members who screened positive for PTSD also screened positive for hazardous alcohol use in a 2018 analysis using VA data
08
3.5% of U.S. adults reported lifetime PTSD in the 2019-2021 National Comorbidity Survey Replication—Adolescent Supplement (NCS-A) follow-up (lifetime measure)
Interpretation
Epidemiology Interpretation
Across epidemiology-focused findings, PTSD remains a persistent public health issue in military populations with rates commonly landing in the high single digits to around a quarter, such as 6.0% of U.S. veterans in 2013 and 23% of active-duty service members showing clinically significant symptoms in 2019.
03 · Category
Service Utilization7 stats
01
From 2010 to 2019, VA’s PTSD specialty care expansion increased the number of veterans receiving specialty PTSD treatment by 48% (VHA reported growth in specialty clinics)
02
In FY 2023, the Veterans Health Administration (VHA) provided 36.5 million mental health appointments across all mental health conditions
03
In 2019-2020, 34% of active-duty service members who screened positive for PTSD symptoms reported receiving mental health treatment within the prior 12 months
04
20% of veterans with PTSD reported using VA telehealth for mental health services in a 2021 survey (telehealth use among those receiving care)
05
In 2023, VA reported 1,000,000+ PTSD-specific therapy sessions delivered via telehealth during the year
06
61% of Veterans Affairs medical centers met or exceeded timeliness benchmarks for PTSD specialty care referrals in 2022 (system-level quality metric)
07
4.9% of Medicare beneficiaries who had served in the military had a PTSD diagnosis in administrative claims analyses (2017 baseline study)
Interpretation
Service Utilization Interpretation
From 2010 to 2019, VA’s PTSD specialty care expansion drove a 48% rise in the number of veterans getting specialty PTSD treatment, underscoring how service utilization has meaningfully increased alongside expanding access.
More related reading
04 · Category
Economic Impact11 stats
01
In a 2016 study, PTSD is associated with a 1.9x increase in health care utilization (measured as visits) compared with non-PTSD cohorts
02
$1.0 billion annual cost attributable to comorbid PTSD and depression in veterans in a 2017 claims analysis
03
$19.5 billion total societal cost estimate for PTSD in the U.S. in 2010 (including employment and criminal justice costs)
04
$12.7 billion indirect cost component (lost productivity) of PTSD in the United States reported in a 2014 economic assessment
05
A 2020 review estimates PTSD treatment costs for veterans range from about $200to $3,500 per episode depending on modality and setting
06
In FY 2022, the VA reported spending $3.6 billion on specialty mental health programs (includes PTSD programs) as part of VHA mental health budget
07
In a workforce absenteeism study, PTSD is associated with a 3.1-day increase in annual absenteeism for employed adults (2019 analysis)
08
$2.5 billion annual estimated cost of PTSD in U.K. (England) health and social care in a 2018 economic model
09
A cost-effectiveness analysis found that prolonged exposure therapy reduced PTSD symptoms with incremental cost-effectiveness of $X per QALY (reported in 2015 study)
10
$1.1 million estimated lifetime cost for a single severe PTSD case due to chronic care and productivity loss (2019 lifetime economic model)
11
In a 2022 JAMA study, PTSD was associated with 1.5 times higher health care costs compared with controls
Interpretation
Economic Impact Interpretation
Overall economic impact data show that PTSD can substantially raise costs and productivity losses, with U.S. estimates reaching $19.5 billion in total societal costs in 2010 and adding 3.1 extra days of annual absenteeism for employed adults, while veterans alone account for about $1.0 billion annually in claims-linked comorbid PTSD and depression.
05 · Category
Treatment Outcomes22 stats
01
In a randomized trial, prolonged exposure therapy achieved a 70% response rate vs 60% for present-centered therapy (2012 study)
02
In a randomized trial, cognitive processing therapy yielded a 59% remission rate vs 36% for control at post-treatment (2013)
03
A meta-analysis reported that trauma-focused CBT reduced PTSD symptom severity with a standardized mean difference (SMD) of about -1.2 versus controls
04
A meta-analysis found EMDR reduced PTSD symptoms with an SMD around -1.0 compared to control conditions
05
In a large VA effectiveness study, about 45% of veterans receiving PE achieved clinically significant improvement (reliable change)
06
In the STRONG STAR trial, 58% of participants receiving web-based CBT for PTSD reported symptom improvement vs 39% in the comparison group
07
In a 2020 meta-analysis, pharmacotherapy for PTSD (e.g., SSRIs) showed a symptom reduction with effect size around Hedges g = -0.40
08
A 2019 VA study reported that 5 sessions of brief cognitive therapy produced a mean reduction of 10 points on the PCL-5 (baseline-to-follow-up)
09
In a 2018 randomized trial, 12 weeks of VA-led internet-based CBT reduced PTSD symptom severity by a mean 18-point decrease on the PCL-5
10
In a 2017 systematic review, mindfulness-based interventions showed moderate improvements in PTSD symptoms (SMD ~ -0.55)
11
In a cohort study, veterans receiving evidence-based PTSD therapy had a 2.7-fold greater probability of employment improvement within 1 year vs non-treated controls
12
In a 2021 trial of ketamine for PTSD, 40% of participants had a clinically meaningful response at 24 hours (defined by symptom scale threshold)
13
In a 2023 review, clinician-led virtual reality exposure therapy produced large reductions in PTSD symptoms with effect sizes around d = 0.8
14
In a trial, 6 sessions of eye movement desensitization and reprocessing (EMDR) reduced PTSD symptom severity by 25% on average from baseline
15
In a 2019 VA evaluation, 12 weeks of group CPT reduced PCL-5 scores by a mean of 13 points among participants with baseline scores ≥33
16
A 2015 meta-analysis found that adding cognitive-behavioral interventions to usual care reduced dropout rates by 20%
17
In a 2022 systematic review, treatment outcomes for PTSD interventions in veterans show pooled remission around 35% across evidence-based therapies
18
In a 2014 RCT, veterans receiving PE had a 22% greater reduction in PTSD symptoms (CAPS score) at post-treatment compared to control
19
In a 2020 trial, TF-CBT for veterans with PTSD reduced comorbid depressive symptoms by 1.3-point MADRS on average
20
In a 2019 study, 1 in 2 veterans receiving PTSD therapy achieved clinically meaningful improvement on the PCL-5 (≥5-point reliable change index threshold)
21
In a 2018 review, prazosin for PTSD-related nightmares reduced nightmare frequency with a weighted mean difference of about 1.7 fewer nights per week vs placebo
22
In a 2021 network meta-analysis, trauma-focused psychotherapies ranked highest for PTSD symptom reduction among interventions
Interpretation
Treatment Outcomes Interpretation
Across these Treatment Outcomes findings, multiple evidence based approaches consistently show meaningful improvement rates and symptom reductions, such as cognitive processing therapy reaching a 59% remission rate and trauma focused CBT averaging an SMD around -1.2, indicating that targeted PTSD treatment in military and veteran settings is producing reliably measurable benefits.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Thomas Lindqvist. (2026, February 13). Ptsd Military Statistics. Gitnux. https://gitnux.org/ptsd-military-statistics
MLA
Thomas Lindqvist. "Ptsd Military Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/ptsd-military-statistics.
Chicago
Thomas Lindqvist. 2026. "Ptsd Military Statistics." Gitnux. https://gitnux.org/ptsd-military-statistics.
Sources & references
59 datasets cited across this report · attribution is report-level
+46 additional datasets cited (not shown individually)